Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer
暂无分享,去创建一个
George A. Calin | Gabriel Lopez-Berestein | G. Calin | A. Sood | M. Bullock | G. Lopez-Berestein | Justyna Filant | Anil K. Sood | Justyna Filant | A. Silva | Mohammed H Rashed | Marc D. Bullock | Andreia M. Silva | Pinar Kanlikilicer-Unaldi | Mohammed H. Rashed | Pinar Kanlikilicer-Unaldi | J. Filant
[1] M. Tewari,et al. Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions , 2014, Nucleic acids research.
[2] Sidhartha Hazari,et al. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. , 2012, The American journal of pathology.
[3] Gunther Hartmann,et al. SiRNA delivery with exosome nanoparticles , 2011, Nature Biotechnology.
[4] G. Illei,et al. Exosomes from human saliva as a source of microRNA biomarkers. , 2010, Oral diseases.
[5] Jian Zhang,et al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells , 2014, Breast Cancer Research and Treatment.
[6] B. Davidson,et al. Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.
[7] Ming Liu,et al. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma , 2014, Medical Oncology.
[8] Dominique,et al. Combining Agents that Target the Tumor Microenvironment Improves the Efficacy of Anticancer Therapy , 2008, Clinical Cancer Research.
[9] Qun Yu,et al. Increased Exosomal MicroRNA-21 and MicroRNA-146a Levels in the Cervicovaginal Lavage Specimens of Patients with Cervical Cancer , 2014, International journal of molecular sciences.
[10] J. Mattick,et al. Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.
[11] W. Jiang,et al. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes , 2014, Oncogene.
[12] C. Mirkin,et al. Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agents. , 2014, Small.
[13] J Ma,et al. MicroRNA and drug resistance , 2010, Cancer Gene Therapy.
[14] J. Benoit,et al. A review of the current status of siRNA nanomedicines in the treatment of cancer. , 2013, Biomaterials.
[15] Shunsuke Noguchi,et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] Y. Matsumura,et al. Exosome can prevent RNase from degrading microRNA in feces. , 2011, Journal of gastrointestinal oncology.
[17] C. Ponting,et al. Evolution and Functions of Long Noncoding RNAs , 2009, Cell.
[18] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[19] F. Sánchez‐Madrid,et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.
[20] G. Calin,et al. MicroRNAome genome: A treasure for cancer diagnosis and therapy , 2014, CA: a cancer journal for clinicians.
[21] Y. Wang,et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells , 2009, Oncogene.
[22] Amaia Agirre,et al. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. , 2014, Neuro-oncology.
[23] Howard Y. Chang,et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.
[24] G. Raposo,et al. Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.
[25] S. Thibodeau,et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing , 2013, BMC Genomics.
[26] G. Packham,et al. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression , 2012, Biology of the cell.
[27] J. Rinn,et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.
[28] H. Nielsen,et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients , 2010, Clinical & Experimental Metastasis.
[29] K. Mimori,et al. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation , 2015, British Journal of Cancer.
[30] Lucy Pigati,et al. MicroRNAs are exported from malignant cells in customized particles , 2012, Nucleic acids research.
[31] A. Engert,et al. Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function , 2008, PloS one.
[32] George A Calin,et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.
[33] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[34] M. Wei,et al. Micro‐RNA‐21 regulates TGF‐β‐induced myofibroblast differentiation by targeting PDCD4 in tumor‐stroma interaction , 2011, International journal of cancer.
[35] Douglas D. Taylor,et al. Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.
[36] G. Szabo,et al. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[37] Y. Toiyama,et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. , 2013, Journal of the National Cancer Institute.
[38] Domenico Coppola,et al. MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer* , 2010, The Journal of Biological Chemistry.
[39] M. Wood,et al. Exosomes for targeted siRNA delivery across biological barriers. , 2013, Advanced drug delivery reviews.
[40] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[41] J. Lötvall,et al. MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma , 2014, BMC Cancer.
[42] Lesley Cheng,et al. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. , 2014, Kidney international.
[43] C. Croce,et al. MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] B. Quah,et al. The immunogenicity of dendritic cell-derived exosomes. , 2005, Blood cells, molecules & diseases.
[45] Shinobu Ueda,et al. Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[46] R. Schiffelers,et al. Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.
[47] G. Almeida-Porada,et al. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. , 2010, Advanced drug delivery reviews.
[48] Shuai Jiang,et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. , 2010, Cancer research.
[49] Lesley Cheng,et al. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood , 2014, Journal of extracellular vesicles.
[50] N. Wang,et al. Isolation and purification of exosomes in urine. , 2010, Methods in molecular biology.
[51] M. Provencio,et al. Different exosome cargo from plasma/bronchoalveolar lavage in non‐small‐cell lung cancer , 2014, Genes, chromosomes & cancer.
[52] T. Patel,et al. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer , 2014, FEBS open bio.
[53] Michael C. Ostrowski,et al. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. , 2014, Cancer research.
[54] Matthias John,et al. RNAi-mediated gene silencing in non-human primates , 2006, Nature.
[55] T. Anchordoquy,et al. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[56] H. Allgayer,et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.
[57] Per Sunnerhagen,et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes , 2012, Nucleic acids research.
[58] K. Pantel,et al. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients , 2014, Oncotarget.
[59] Aled Clayton,et al. Cancer exosomes trigger fibroblast to myofibroblast differentiation. , 2010, Cancer research.
[60] F. Slack,et al. Junk DNA and the long non-coding RNA twist in cancer genetics , 2015, Oncogene.
[61] Raghu Kalluri,et al. Exosomes in tumor microenvironment influence cancer progression and metastasis , 2013, Journal of Molecular Medicine.
[62] S. Zhong,et al. Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs , 2014, PloS one.
[63] D. Barh,et al. Microrna let-7: an emerging next-generation cancer therapeutic , 2010, Current oncology.
[64] S. Kauppinen,et al. Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.
[65] J. Cooper,et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice , 2014, Movement disorders : official journal of the Movement Disorder Society.
[66] Howard Y. Chang,et al. Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.
[67] Cicek Gercel-Taylor,et al. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.
[68] G. Calin,et al. Exosomes as divine messengers: are they the Hermes of modern molecular oncology? , 2014, Cell Death and Differentiation.
[69] H. Ishwaran,et al. Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways , 2014, Cell.
[70] Keith L Ligon,et al. Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity , 2013, Molecular therapy. Nucleic acids.
[71] Tao Wang,et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. , 2015, European urology.
[72] Naoto Tsuchiya,et al. Circulating Exosomal microRNAs as Biomarkers of Colon Cancer , 2014, PloS one.
[73] Muneesh Tewari,et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes , 2014, Proceedings of the National Academy of Sciences.
[74] M. Wood,et al. Biological gene delivery vehicles: beyond viral vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[75] Zuhong Lu,et al. miRNA in Plasma Exosome is Stable under Different Storage Conditions , 2014, Molecules.
[76] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[77] J. Woodburn,et al. The epidermal growth factor receptor and its inhibition in cancer therapy. , 1999, Pharmacology & therapeutics.
[78] Jiang He,et al. In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery , 2014, International journal of nanomedicine.
[79] N. Smalheiser. Exosomal transfer of proteins and RNAs at synapses in the nervous system , 2007, Biology Direct.